Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen

被引：52

作者：

Friend, J ^{[1
]}

Parkin, N

Liegler, T

Martin, JN

Deeks, SG

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA

[2] San Francisco Gen Hosp, San Francisco, CA 94110 USA

[3] Virologic, San Francisco, CA USA

[4] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA

来源：

AIDS | 2004年 / 18卷 / 14期

关键词：

D O I：

10.1097/00002030-200409240-00016

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1965 / 1966

页数：2

共 6 条

[1] In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor [J].

Carrillo, A ;

Stewart, KD ;

Sham, HL ;

Norbeck, DW ;

Kohlbrenner, WE ;

Leonard, JM ;

Kempf, DJ ;

Molla, A .

JOURNAL OF VIROLOGY, 1998, 72 (09) :7532-7541

[2]

HSU A, 2002, P 3 INT WORKSH CLIN

[3]

Kagan R, 2003, ANTIVIR THER, V8, pS54

[4] Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistance [J].

Parkin, NT ;

Chappey, C ;

Petropoulos, CJ .

AIDS, 2003, 17 (07) :955-961

[5] Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection [J].

Walmsley, S ;

Bernstein, B ;

King, M ;

Arribas, J ;

Beall, G ;

Ruane, P ;

Johnson, M ;

Johnson, D ;

Lalonde, R ;

Japour, A ;

Brun, S ;

Sun, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) :2039-2046

[6] Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates [J].

Whitcomb, JM ;

Parkin, NT ;

Chappey, C ;

Hellmann, NS ;

Petropoulos, CJ .

JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07) :992-1000

← 1 →